These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Resolution of thyroxine hormone enantiomers by precolumn derivatization with a fluorescent chiral reagent using reversed-phase high performance liquid chromatography].
    Author: Jia S, Zhang M, Jin D.
    Journal: Se Pu; 2008 Sep; 26(5):559-62. PubMed ID: 19160753.
    Abstract:
    A highly fluorescent chiral tagging reagent, R(-)-4-(N,N-dimethylaminosulfonyl)-7-(3-isothiocy-anatopyrrolidino)-2,1,3-benzoxadiazole (R(-)-DBD-PyNCS), was employed for the enantiomer separation of thyroxine hormone, D,L-3,5,3',5'-tetraiodothyronine (T4) and L-3,5,3'-triiodothyronine (T3). The reaction of R(-)-DBD-PyNCS with the thyroxine enantiomers was carried out at 40 degrees C for 20 min under a basic medium surrounding to yield the corresponding pair of diastereomers. No racemization occurs during the tagging reaction under the optimized conditions. Various experimental parameters for the derivatization reaction including the concentration of tagging reagent, reaction temperature and reaction time have been studied in order to get the highest yield of T4/T3 derivatives. The structures of T4/T3 derivatives were identified based on high performance liquid chromatography-mass spectrometry (HPLC-MS) measurement in negative mode. The efficient separation of derivatives have been achieved by isocratic elution with a water-acetonitrile mobile phase containing 1% acetic acid in a reversed-phase column utilizing a conventional fluorescence detector. The calibration curves of L-T3, D,L-T4 were linear over the concentration ranges of 0.0067-0.22 microg/microL and 0.016-0.30 microg/microL, respectively. The limits of detection (S/N = 3) for L-T3 and D,L-T4 were 0.85 microg/mL and 0.02 microg/mL, respectively. The proposed method has been successfully applied to the determination of T3 and T4 in clinical pharmaceutics.
    [Abstract] [Full Text] [Related] [New Search]